Dual mechanisms of repression of E2F1 activity by the retinoblastoma gene product

EMBO Journal

Volumn 15, Issue 21, 1996, Pages 5917-5927

  Zacksenhaus, Eldad ^a,b   Jiang, Zhe ^a   Phillips, Robert A ^a,c   Gallie, Brenda L ^a,c  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

E2F; Nuclear transport; pRb; Retinoblastoma; Transcriptional repression

Indexed keywords

TRANSCRIPTION FACTOR E2F;

ANIMAL CELL; ARTICLE; BINDING SITE; CELLULAR DISTRIBUTION; CYTOPLASM; GENE; GENE EXPRESSION; GENE REPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ANIMALIA;

EID: 0029856734     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1460-2075.1996.tb00978.x     Document Type: Article

References (66)

1. Arroyo and Raychaudhuri (1992) Retinoblastoma-repression of E2F-dependent transcription depends on the ability of the retinoblastoma protein to interact with E2F and is abrogated by the adenovirus E1A oncoprotein. Nucleic Acids Res., 20, 5947-5954.
2. Bandara, L.R., Lam, E.W.-F., Sorensen, T.S., Zamanian, M., Girling, R. and La Thangue, N.B. (1994) DP-1: a cell cycle-regulated and phosphorylated component of transcription factor DRTF1/E2F which is functionally important for recognition by pRb and the adenovirus E4 orf 6/7 protein. EMBO J., 13, 3104-3114.
3. Beijersbergen, R.L., Kerkhoven, R.M., Zhu, L., Carlée, L., Voorhoeve, P.M. and Bernards, R. (1994) E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo. Genes Dev., 8, 2680-2690.
4. Buchkovich, K., Duffy, L.A. and Harlow, E. (1989) The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell, 58, 1097-1105.
5. Chellappan, S.P., Hiebert, S., Mudryl, M., Horowitz, J.M. and Nevins, J.R. (1991) The E2F transcription factor is a cellular target for the RB protein. Cell, 65, 1053-1061.
6. Chen, P.L., Scully, P., Shew, J.Y., Wang, J.Y. and Lee, W.H. (1989) Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell, 58, 1193-1198.
7. DeCaprio, J.A., Ludlow, J.W., Figge, J., Shew, J.Y., Huang, C.M., Lee, W.H., Marsilio, E., Paucha, E. and Livingston, D.M. (1988) SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell, 54, 275-283.
8. DeCaprio, J.A., Ludlow, J.W., Lynch, D., Furukawa, Y., Griffin, J., Piwnica, W.H., Huang, C.M. and Livingston, D.M. (1989) The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell, 58, 1085-1095.
9. Defeo-Jones, D., Huang, P.S., Jones, R.E., Haskell, K.M., Vuocolo, G.A., Hanobik, M.G., Huber, H.E. and Oliff, A. (1991) Cloning of cDNAs for cellular proteins that bind to the retinoblastoma gene product. Nature, 352, 251-254.
10. Degregori, J., Kowalik, T. and Nevins, J.R. (1995) Cellular targets for activation by the E2F1 transcription factor include DNA synthesis-and G1/S-regulatory genes. Mol. Cell. Biol., 15, 4215-4224.
11. Dingwall, C. Sharnick, S.V. and Laskey, R.A. (1982) A polypeptide domain that specifies migration of nucleoplasmin into the nucleus. Cell, 30, 449-458.
12. Dunaief, J.L., Strober, B.E., Guha, S., Khavari, P.A., Ålin, K., Luban, J., Begemann, M., Crabtree, G.R. and Goff, S.P. (1994) The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest. Cell, 79, 119-130.
13. Dyson, N., Howley, P.M., Münger, K. and Harlow, E. (1989) The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science, 242, 934-937.
14. Ewen, M., Xing, Y., Lawrence, J.B. and Livingston, D. (1991) Molecular cloning, chromosomal mapping, and expression of the cDNA for p107, a retinoblastoma gene product-related protein. Cell, 66, 1155-1164.
15. Fagan, R., Flint, K.J. and Jones, N. (1994) Phosphorylation of E2F-1 modulates its interaction with the retinoblastoma gene product and the adenoviral E4 19 kDa protein. Cell, 78, 799-811.
16. Field, S.J., Tsai, F.Y., Kuo, F., Zubiage, A.M., Kaelin, W.G., Livingston, D.M., Orkin, S.H. and Greenberg, M.E. (1996) E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell, 85, 549-561.
17. Gallie, B.L. (1994) Retinoblastoma gene mutations in human cancer N. Engl. J. Med., 330, 786-787.
18. Giguere, V., Hollenberg, S.M., Rosenfeld, M.G. and Evans, R.M. (1986) Functional domains of the human glucocorticoid receptor. Cell, 46, 645-652.
19. Ginsberg, D., Vairo, G., Chittenden, T., Xiao, Z.-X., Xu, G., Wydner, K.L., DeCaprio, J.A., Lawrence, J.A. and Livingston, D.M. (1994) E2F-4, a new member of the E2F transcription factor family, interacts with p107. Genes Dev., 8, 2665-2679.
20. 1 phase of the cell cycle. Cell, 67, 293-302.
21. Gu, W., Schneider, J.W., Condorelli, G., Kaushal, S., Mahdavi, V. and Nadal-Ginard, B. (1993) Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell, 72, 309-324.
22. Guiochon-Mantel, A., Loosfelt, H., Lescop, P., Sar, S., Atger, M., Perrot-Applanat, M. and Milgrom, E. (1989) Mechanisms of nuclear localization of the progesterone receptor: evidence for interaction between monomers. Cell, 57, 1147-1154.
23. Hagemeier, C., Bannister, A.J., Cook, A. and Kouzarides, T. (1993a) The activation domain of transcription factor PU.I binds the retinoblastoma (RB) protein and the transcription factor TFIID in vitro: RB shows sequence similarity to TFIID and TFIIB. Proc. Natl Acad. Sci. USA, 90, 1580-1584.
24. Hagemeier, C., Cook, A. and Kouzarides, T. (1993b) The retinoblastoma protein binds E2F residues required for activation in vivo and TBP binding in vitro. Nucleic Acids Res., 21, 4998-5004.
25. Hamel, P.A., Gill, R.M., Phillips, R.A. and Gallie, B.L. (1992) Transcriptional repression of the E2-containing promoters EIIaE, c-myc, and RB1 by the product of the RB1 gene. Mol. Cell. Biol., 12, 3431-3438.
26. Hannon, G.J., Demetrick, D. and Beach, D. (1993) Isolation of the Rb-related p130 through its interaction with CDK2 and cyclins. Genes Dev., 7, 2378-2391.
27. Helin, K. and Harlow, E. (1994) Heterodimerization of the transcription factors E2F-1 and DP-1 is required for binding to the adenovirus E4 (ORF6/7) protein. J. Virol., 68, 5027-5035.
28. Helin, K., Wu, C.L., Fattaey, A.R., Lees, J.A., Dynlacht, B.D., Ngwu, C. and Harlow, E. (1993) Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative trans-activation. Genes Dev., 7, 1850-1861.
29. Hiebert, S.W., Chellapan, S.P., Horowitz, J.M. and Nevins, J.R. (1992) The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. Genes Dev., 6, 177-185.
30. Hijmans, E.M., Voorhoeve, P.M., Beijersbergen, R.L., van't Veer, L.J. and Bernards, R. (1995) E2F-5, a new E2F family member that interacts with p130 in vivo. Mol. Cell. Biol., 15, 3082-3089.
31. Hsiao, K.M., McMahon, S.L. and Farnham, P.J. (1994) Multiple DNA elements are required for the growth regulation of the mouse E2F1 promoter. Genes Dev., 8, 1526-1537.
32. Huang, S., Lee, W.-H. and Lee, E.Y.-H.P. (1991) A cellular protein that competes with SV40 T antigen for binding to the retinoblastoma gene product. Nature, 350, 160-162.
33. Johnson, D.G., Ohtani, K. and Nevins, J.R. (1994) Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression. Genes Dev., 8, 1514-1525.
34. Kang, K.I., Devin, J., Cadepond, F., Jibard, N., Guiochon-Mantel, A., Baulieu, E.E. and Catelli, M.G. (1994) In vivo functional protein-protein interaction: nuclear targeted hsp90 shifts cytoplasmic steroid receptor mutants into the nucleus. Proc. Natl Acad. Sci. USA, 91. 340-344.
35. Kim, S.J., Wagner, S., Liu, F., O'Reilly, M.A., Robbins, P.D. and Green, M.R. (1992) Retinoblastoma gene product activates expression of the human TGF-beta 2 gene through transcription factor ATF-2. Nature, 358, 331-334.
36. Lam, E.W., Morris, J.D., Davies, R., Crook, T., Watson, R.J. and Vousden, K.H. (1994) HPV16 E7 oncoprotein deregulates B-myb expression: correlation with targeting of p107/E2F complexes. EMBO J., 13, 871-878.
37. Lanford, R.E. and Butel, J.S. (1984) Construction and characterization of an SV40 mutant defective in nuclear transport of T antigen. Cell, 37, 801-813.
38. Li, Y., Graham, C., Lacy, S., Duncan, A.M. and Whyte, P. (1993) The adenovirus E1A-associated 130-kD protein is encoded by a member of the retinoblastoma gene family and physically interacts with cyclins A and E. Genes Dev., 7, 2366-2377.
39. Loeken, M.R. and Brady, J. (1989) The adenovirus EIIA enhancer. J. Biol. Chem., 264, 6572-6579.
40. Makela, T.P., Koskinen, P.J., Vaastrik, I. and Alitalo, K. (1992) Alternative forms of Max as enhancers or suppressors of Myc-Ras cotransformation. Science, 256, 373-377.
41. Mittnacht, S. and Weinberg, R.A. (1991) G1/S phosphorylation of the retinoblastoma protein is associated with an altered affinity for the nuclear compartment. Cell, 65, 381-393.
42. Moreland, R.B., Langevin, G.L., Singer, R.H., Garcea, R.L. and Hereford, L.M. (1987) Amino acid sequences that determine the nuclear localization of yeast histone 2B. Mol. Cell. Biol., 7, 4048-4057.
43. Pardee, A.B. (1990) G1 events and regulation of the cell proliferation. Science, 246, 603-608.
44. Picard, D. and Yamamoto, D.R. (1987) Two signals mediate hormone-dependent nuclear localization of the glucocorticoid receptor. EMBO J., 6, 3333-3340.
45. Qin, X.Q., Livingston, D.M., Ewen, M., Sellers, W.R., Arany, Z. and Kaelin, W.G. Jr (1995) The transcription factor E2F-1 is a downstream target of RB action. Mol. Cell. Biol., 15, 742-755.
46. Rusconi, S. and Yamamoto, K.R. (1987) Functional dissection of the hormone and DNA binding activities of the glucocorticoid receptor. EMBO J., 6, 1309-1315.
47. Sardet, C., Vidal, M., Cobrinik, D., Geng, Y., Onufryk, C., Chen, A. and Weinberg, R.A. (1995) E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle. Proc. Natl Acad. Sci. USA, 92, 2403-2407.
48. Scheffner, M., Münger, K., Byrne, J.C. and Howley, P.M. (1991) The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc. Natl Acad Sci. USA, 88, 5523-5527.
49. Schneider, J.W., Gu, W., Zhu, L., Mahdavi, V. and Nadal-Ginard, B. (1994) Reversal of terminal differentiation mediated by p107 in Rb-/- muscle cells. Science, 264, 1467-1471.
50. Sherr, C.J. and Roberts, J.M. (1995) Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev., 9, 1149-1163.
51. Singh, P., Coe, J. and Hong, W. (1995) A role for retinoblastoma protein in potentiating transcriptional activation by the glucocorticoid receptor. Nature, 374, 562-565.
52. Templeton, D.J., Park, S.H., Lanier, L. and Weinberg, R.A. (1991) Non-functional mutants of the retinoblastoma protein are characterized by defects in phosphorylation, viral oncoprotein association, and nuclear tethering. Proc. Natl Acad. Sci. USA, 88, 3033-3037.
53. Vairo, G., Livingston, D.M. and Ginsberg, D. (1995) Functional interaction between E2F-4 and p130: evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members. Genes Dev., 9, 869-881.
54. Wang, C.Y., Petryniak, B., Thompson, C.B., Kaelin, W.G. and Leiden, J.M. (1993) Regulation of the Ets-related transcription factor Elf-1 by binding to the retinoblastoma protein. Science, 260, 1330-1335.
55. Wang, J.Y.J., Knudsen, E.S. and Welch, P.J. (1994) The retinoblastoma tumor suppressor protein. Adv. Cancer Res., 64, 25-86.
56. Weinberg, R.A. (1995) The retinoblastoma protein and cell cycle control. Cell, 81, 323-330.
57. Weintraub, S.J., Prater, C.A. and Dean, D.C. (1992) Retinoblastoma protein switches the E2F site from positive to negative element. Nature, 358, 259-261.
58. Weintraub, S.J., Chow, K.N.B., Luo, R.X., Zhang, S.H., He, S. and Dean, D.C. (1995) Mechanism of active transcriptional repression by the retinoblastoma protein. Nature, 375, 812-815.
59. Welch, P.J. and Wang, J.Y.J. (1995) Disruption of retinoblastoma protein function by coexpression of its C pocket fragment. Genes Dev., 9, 31-46.
60. Whyte, P., Buchkovich, K.J., Horowitz, J.M., Friend, S.H., Raybuck, M., Weinberg, R.A. and Harlow, E. (1988) Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature, 334, 124-129.
61. Xiao et al. (1995) Interaction between the retinoblastoma protein and the oncoprotein MDM2. Nature, 375, 694-698.
62. Yamasaki, L., Jacks, T., Bronson, R., Goillot, E., Harlow, E. and Dyson, N.J. (1996) Tumor induction and tissue atrophy in mice lacking E2F-1. Cell, 85, 537-548
63. Zacksenhaus, E., Bremner, R., Jiang, Z., Gill, R.M., Muncaster, M., Sopta, M., Phillips, R.A. and Gallie, B.L. (1993a) Unraveling the function of the retinoblastoma gene. Adv. Cancer Res., 61, 115-141.
64. Zacksenhaus, E., Bremner, R., Phillips, R.A. and Gallie, B.L. (1993b) A bipartite nuclear localization signal in the retinoblastoma gene product and its importance for biological activity. Mol. Cell. Biol., 13, 4588-4599.
65. Zacksenhaus, E., Gill, R.M., Phillips, R.A. and Gallie, B.L. (1993c) Molecular cloning and characterization of the mouse RB1 promoter. Oncogene, 8, 2343-2351.
66. Zamanian, M. and La Thangue.N.B. (1992) Adenovirus E1a prevents the retinoblastoma gene product from repressing the activity of a cellular transcription factor. EMBO J., 11, 2603-2610.